Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 2, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.
Shanghai-based I-Mab has signed a global collaboration deal with U.S. drug maker AbbVie to develop lemzoparlimab, I-Mab’s homegrown cancer immunotherapy.
As Blueprint Medicines preps for the U.S. and EU approvals of its RET inhibitor, the company is bringing its research and clinical development work under one roof and putting Bristol Myers ...
The biopharma industry has raised a total of about $88 billion so far in 2020, the most ever for a single year, with four months to go. It hit the record in July when it surpassed the $68.4 ...
Tens of thousands of users are sharing a series of claims that link Dr. Anthony Fauci, Bill Gates, George Soros and Jeffrey Epstein to Moderna, one of the leading contenders in the race to ...
Celyad Oncology is at the forefront of cutting-edge immunotherapy and is hopeful of providing a new way forward for patients with relapsed/refractory multiple myeloma.
2nd ANNUAL PAWS FOR A CURE VIRTUAL EVENT RESEARCH SYMPOSIUM Translational Potential Of Comparative Approaches To Accelerate Drug Development In Shared Childhood & Canine Cancers We are